Genetic epidemiology studies have suggested the responsibility of genetic f
actors in prostate cancer susceptibility. The development of genomic and hi
gh throughput genetic studies has allowed the recent identification or loca
lization of such susceptibility genes. Furthermore, these technologies have
contributed to outstanding advances in somatic genetics of prostate cancer
. The goal of the present review is to disclose contributing technologies t
o and results of genetic studies of prostate cancer.